Section Arrow
GKOS.NYSE
- Glaukos Corp
Quotes are at least 15-min delayed:2025/01/21 05:37 EST
Last
 156.39
-0.12 (-0.08%)
Day High 
157.83 
Prev. Close
156.51 
1-M High
161.13 
Volume 
529.06K 
Bid
151.01
Ask
158.13
Day Low
153.675 
Open
157.24 
1-M Low
141.53 
Market Cap 
8.63B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 153.37 
20-SMA 151.13 
50-SMA 144.37 
52-W High 161.13 
52-W Low 83.9 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-2.93/0.10
Enterprise Value
9.01B
Balance Sheet
Book Value Per Share
12.12
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
314.71M
Operating Revenue Per Share
5.51
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
QSIQuantum-Si2.24-0.3-11.81%-- 
SENSSenseonics Holdings0.8479-0.0271-3.10%-- 
BDMDBaird Medical Investment Holdings Ltd8.85+3.43+63.28%15.32PE
BMRABiomerica0.64-0.066-9.35%-- 
MDTMedtronic plc88.08+0.92+1.06%26.61PE
Quotes are at least 15-min delayed:2025/01/21 05:37 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.